Analysis Report #SUNPHARMA
Stock Analysis : Sun Pharmaceutical Industries Ltd. Overview : Sun Pharmaceutical Industries Limited ( NSE: SUNPHARMA, BSE: 524715 ) is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology and diabetology. It also provides APIs such as warfarin, carbamazepine, etodolac, and clorazepate, as well as anticancers, steroids, peptides, sex hormones, and controlled substances. Technical View : Sun Pharma is cracking 7-8% from 563 to 515 ahead of the US FDA inspection scheduled in next few days. No One knows what’s the outcome. However Technically, the overall structure of the charts is weak. Stock has broken an important support 540 joining the rising trend-line support from l...
Comments
Post a Comment